SyntheX Company
SyntheX is a biotechnology firm developing highly specific drugs for previously undruggable targets to treat cancer and rare diseases.
Technology:
Cancer
Industry:
PharmTech
Headquarters:
San Francisco, California, United States
Founded Date:
2016
Employees Number:
11-50
Funding Status:
Seed
Estimated Revenue:
$1M to $10M
Register and Claim Ownership